XHE Performance — State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF
Data updated: 2026-09-11
XHE returned −4.53% year to date and +3.52% over one year to Jun 2026. Annualised returns are −5.00% over 3 years and −8.17% over 5 years. The fund trailed its Health Care Equity category average: $100 invested three years ago grew to $86, against $138 for the category, and to $104 over one year, against $137. Volatility over the past three years was 22.42% a year. In the 12 months to Jun 2026 the fund lost a net $19.7M, and assets reached $151.44M.
XHE Growth of $100
What $100 invested in State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.
| Period | XHE | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $104 | $137 |
| 3 years (Jul 2023 – Jun 2026) | $86 | $138 |
| 5 years (Jul 2021 – Jun 2026) | $65 | $121 |
| Since data start (Jul 2019 – Jun 2026) | $103 | $182 |
XHE Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −4.53% |
| 1 year | +3.52% |
| 3 years (annualised) | −5.00% |
| 5 years (annualised) | −8.17% |
XHE Annual Returns
Calendar-year total returns of State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | −4.53% |
| 2025 | −0.55% |
| 2024 | +5.07% |
| 2023 | −5.98% |
| 2022 | −23.49% |
| 2021 | +3.19% |
| 2020 | +32.68% |
| 2019 (Jul–Dec) | +4.77% |
XHE Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −1.8% | +2.1% | −11.3% | +3.5% | −1.9% | +5.8% | — | — | — | — | — | — |
| 2025 | +6.9% | −6.5% | −7.1% | −4.0% | +2.8% | +0.1% | −6.3% | +7.8% | −4.1% | +1.3% | +11.5% | −0.9% |
| 2024 | −0.7% | +0.9% | +3.9% | −6.7% | +4.9% | −1.9% | +1.2% | +5.0% | +0.7% | −3.0% | +7.1% | −5.5% |
| 2023 | +6.5% | −2.8% | +0.7% | +4.3% | −4.7% | +5.5% | 0.0% | −11.7% | −10.1% | −12.7% | +10.1% | +12.6% |
| 2022 | −11.7% | +5.3% | +2.5% | −14.9% | −4.5% | −6.6% | +10.1% | −1.0% | −8.0% | +3.7% | +3.8% | −2.1% |
| 2021 | +4.0% | +1.7% | −0.8% | +5.4% | −3.9% | +6.7% | +0.6% | +0.8% | −4.5% | +0.6% | −10.2% | +4.0% |
| 2020 | −0.6% | −6.2% | −10.3% | +16.4% | +5.4% | +1.4% | +6.8% | +1.5% | +0.6% | +0.1% | +8.6% | +7.5% |
| 2019 | — | — | — | — | — | — | +1.6% | −4.1% | −2.0% | +1.1% | +8.0% | +0.5% |
XHE Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 22.42%
- 3-year Sharpe ratio: -0.42 (vs 4.5% risk-free rate)
- Best month: +12.58% (Dec 2023)
- Worst month: −12.68% (Oct 2023)
XHE Fund Flows
Monthly money in and out of State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF, from SEC Form N-PORT.
- 12-month net flow: −$19.7M
- 12-month gross sales (incl. reinvestments): $155.9M
- Sales ÷ redemptions: 0.89×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $36.0M | $19.9M | $16.1M |
| May 2026 | $5.9M | $5.9M | −$90K |
| Apr 2026 | $31.0M | $41.1M | −$10.2M |
| Mar 2026 | $11.9M | $9.9M | $2.0M |
| Feb 2026 | $0 | $0 | $0 |
| Jan 2026 | $11.4M | $15.5M | −$4.1M |
| Dec 2025 | $11.0M | $8.9M | $2.1M |
| Nov 2025 | $12.7M | $12.4M | $363K |
| Oct 2025 | $28.1M | $32.1M | −$4.0M |
| Sep 2025 | $0 | $10.0M | −$10.0M |
| Aug 2025 | $2.0M | $6.1M | −$4.1M |
| Jul 2025 | $5.9M | $13.7M | −$7.8M |
XHE Assets Under Management
Net assets of State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $151.44M |
| 2026-03-31 | $135.15M |
| 2025-12-31 | $154.22M |
| 2025-09-30 | $139.87M |
| 2025-06-30 | $166.72M |
| 2025-03-31 | $174.98M |
| 2024-12-31 | $212.86M |
| 2024-09-30 | $223.65M |
| 2024-06-30 | $244.83M |
| 2024-03-31 | $285.74M |
| 2023-12-31 | $350.39M |
| 2023-09-30 | $376.53M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.